Inventor · disambiguated record
Donald C. Monkhouse
Also filed as: MONKHOUSE DONALD · MONKHOUSE DONALD C
20 granted patents·5 pending applications·876 citations·filing 1975–2022
96Inventor score
Files withTHERICS INC7Aprecia Pharmaceuticals LLC4APRECIA PHARMACEUTICALS CO3MASSACHUSETTS INST TECHNOLOGY2PFIZER2
Top patents by PatentIndex Score
25 records- 0196US6547994B1Rapid prototyping and manufacturing processTHERICS INC·Filed 1999·Granted Apr 15, 2003·149 cites·22 claims
- 0296US6514518B2Dosage forms exhibiting multi-phasic release kinetics and methods of manufacture thereofTHERICS INC·Filed 2001·Granted Feb 4, 2003·118 cites·18 claims
- 0394US9669009B2Rapid disperse dosage form containing levetiracetamAPRECIA PHARMACEUTICALS CO·Filed 2016·Granted Jun 6, 2017·8 cites·30 claims
- 0494US9339489B2Rapid disperse dosage form containing levetiracetamJACOB JULES·Filed 2014·Granted May 17, 2016·25 cites·26 claims
- 0594US6471992B1Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of sameTHERICS INC·Filed 1998·Granted Oct 29, 2002·123 cites·20 claims
- 0692US12396979B2Rapid disperse dosage formAprecia Pharmaceuticals LLC·Filed 2022·Granted Aug 26, 2025·1 cites·20 claims
- 0792US7276252B2Method and form of a drug delivery device, such as encapsulating a toxic core within a non-toxic region in an oral dosage formMASSACHUSETTS INST TECHNOLOGY·Filed 2001·Granted Oct 2, 2007·54 cites·31 claims
- 0891US9492380B2Rapidly dispersible dosage form of topiramateAPRECIA PHARMACEUTICALS CO·Filed 2015·Granted Nov 15, 2016·15 cites·16 claims
- 0990US4946838ACrystalline anhydrous aztreonamSQUIBB & SONS INC·Filed 1986·Granted Aug 7, 1990·38 cites·6 claims
- 1088US8828411B2Dosage forms and methods of use thereofYOO JAE D·Filed 2007·Granted Sep 9, 2014·22 cites·22 claims
- 1187US11160786B2Rapid disperse dosage formAprecia Pharmaceuticals LLC·Filed 2017·Granted Nov 2, 2021·2 cites·19 claims
- 1283US10420785B2Rapidly dispersible dosage form of topiramateAprecia Pharmaceuticals LLC·Filed 2016·Granted Sep 24, 2019·4 cites·16 claims
- 1382US7122057B2Method and apparatus for engineered regenerative biostructures such as hydroxyapatite substrates for bone healing applicationsTHERICS LLC·Filed 2002·Granted Oct 17, 2006·111 cites·60 claims
- 1482US3954787AStabilized E-series prostaglandinsPFIZER·Filed 1975·Granted May 4, 1976·13 cites·11 claims
- 1581US9463160B2Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of sameYOO JAEDEOK·Filed 2002·Granted Oct 11, 2016·10 cites·34 claims
- 1679US9114072B2Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of sameYOO JAEDEOK·Filed 2012·Granted Aug 25, 2015·13 cites·23 claims
- 1774US7875290B2Method and form of a drug delivery device, such as encapsulating a toxic core within a non-toxic region in an oral dosage formMASSACHUSETTS INST TECHNOLOGY·Filed 2005·Granted Jan 25, 2011·27 cites·27 claims
- 1873US6280771B1Dosage forms exhibiting multi-phasic release kinetics and methods of manufacture thereofTHERICS INC·Filed 1998·Granted Aug 28, 2001·119 cites·15 claims
- 1965US2017258763A1Rapid disperse dosage formAPRECIA PHARMACEUTICALS CO·Filed 2017·Application pending·0 cites
- 2065US2022211668A1Rapid disperse dosage formAprecia Pharmaceuticals LLC·Filed 2022·Application pending·0 cites
- 2158US4344940ASteroid formulation containing dipotassium EDTASQUIBB & SONS INC·Filed 1981·Granted Aug 17, 1982·18 cites·18 claims
- 2258US2004062814A1Method and materials for controlling migration of binder liquid in a powderTHERICS INC·Filed 2003·Application pending·0 cites
- 2348US3952004AStabilized E-series prostaglandinsPFIZER·Filed 1975·Granted Apr 20, 1976·6 cites·11 claims
- 2443US2003173695A1Rapid prototyping and manufacturing processTHERICS INC·Filed 2003·Application pending·0 cites
- 2541US2003114936A1Complex three-dimensional composite scaffold resistant to deliminationTHERICS INC·Filed 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Donald C. Monkhouse files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →